Healthcare technology company Phreesia (NYSE:PHR) will be reporting results tomorrow after the bell. Here’s what to look for.
Phreesia beat analysts’ revenue expectations by 0.6% last quarter, reporting revenues of $106.8 million, up 16.6% year on year. It was an exceptional quarter for the company, with an impressive beat of analysts’ EPS estimates and full-year EBITDA guidance exceeding analysts’ expectations. It added 68 customers to reach a total of 4,237.
Is Phreesia a buy or sell going into earnings? Read our full analysis here, it’s free.
This quarter, analysts are expecting Phreesia’s revenue to grow 14.7% year on year to $109 million, slowing from the 24.1% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.11 per share.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Phreesia has a history of exceeding Wall Street’s expectations, beating revenue estimates every single time over the past two years by 1.5% on average.
Looking at Phreesia’s peers in the healthcare technology for providers segment, some have already reported their Q4 results, giving us a hint as to what we can expect. Privia Health delivered year-on-year revenue growth of 4.6%, beating analysts’ expectations by 9.4%, and Astrana Health reported revenues up 88.4%, topping estimates by 6.9%. Privia Health traded up 3.8% following the results while Astrana Health was down 27%.
Read our full analysis of Privia Health’s results here and Astrana Health’s results here.
Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we’ve identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link.